Jason Litten
CIK: 0001909400
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
GNLX
GENELUX Corp
Officer
Discretionary Trading P&L
Holdings
About Litten Jason
Litten Jason (SEC CIK 0001909400) files insider reports with the SEC as Chief Medical Officer of GENELUX Corp (GNLX).
Signal8 holds 2 ownership filings by Litten Jason (1 Form 3, 1 Form 4), filed on Jan 7, 2026. Those filings report 1 transaction, the latest on Jan 2, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Litten Jason's filings is in WESTLAKE VILLAGE, CA.
Recent filings by Litten Jason
- Jan 2, 2026: Grant or award of GNLX derivative securities (Form 4, code A).
Other insiders filing for GENELUX Corp (GNLX)
- Cappello Joseph, Chief Technical Officer
- Zindrick Thomas, President and CEO
- Yu Yong, Chief Scientific Officer
- Smither John W, Director
- Pulisic Matthew, Chief Financial Officer
- Groen Eric, General Counsel